Korpela R

ORCID: 0000-0003-0337-9186 · 2 papers in corpus

2010

Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes.

BMC gastroenterology ·doi:10.1186/1471-230x-10-110

BackgroundProbiotics can alleviate the symptoms of irritable bowel syndrome (IBS), possibly by stabilizing the intestinal microbiota. Our aim was to determine whether IBS-associated bacterial alterations were reduced during multispecies pro…

2009

Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.

World journal of gastroenterology ·doi:10.3748/wjg.15.6068

AimTo investigate the pathophysiology of irritable bowel syndrome (IBS) by comparing the global mucosal metabolic profiles of IBS patients with those of healthy controls.MethodsFifteen IBS patients fulfilling the Rome II criteria, and nine …